- Home
- WGSWW vs GTERU Comparison
WGSWW vs GTERU Comparison
Compare WGSWW & GTERU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WGSWW
- GTERU
- Stock Information
- Founded
- WGSWW 2017
- GTERU N/A
- Country
- WGSWW United States
- GTERU Mexico
- Employees
- WGSWW 1000
- GTERU N/A
- Industry
- WGSWW Retail: Computer Software & Peripheral Equipment
- GTERU Blank Checks
- Sector
- WGSWW Technology
- GTERU Finance
- Exchange
- WGSWW Nasdaq
- GTERU Nasdaq
- Market Cap
- WGSWW N/A
- GTERU N/A
- IPO Year
- WGSWW N/A
- GTERU 2025
- Fundamental
- Price
- WGSWW $0.08
- GTERU $10.27
- Analyst Decision
- WGSWW
- GTERU
- Analyst Count
- WGSWW 0
- GTERU 0
- Target Price
- WGSWW N/A
- GTERU N/A
- AVG Volume (30 Days)
- WGSWW 36.6K
- GTERU N/A
- Earning Date
- WGSWW 02-18-2025
- GTERU N/A
- Dividend Yield
- WGSWW N/A
- GTERU N/A
- EPS Growth
- WGSWW N/A
- GTERU N/A
- EPS
- WGSWW N/A
- GTERU N/A
- Revenue
- WGSWW $305,450,000.00
- GTERU N/A
- Revenue This Year
- WGSWW N/A
- GTERU N/A
- Revenue Next Year
- WGSWW N/A
- GTERU N/A
- P/E Ratio
- WGSWW N/A
- GTERU N/A
- Revenue Growth
- WGSWW 50.79
- GTERU N/A
- 52 Week Low
- WGSWW $0.17
- GTERU N/A
- 52 Week High
- WGSWW $0.21
- GTERU N/A
- Technical
- Relative Strength Index (RSI)
- WGSWW 45.05
- GTERU N/A
- Support Level
- WGSWW $0.07
- GTERU N/A
- Resistance Level
- WGSWW $0.10
- GTERU N/A
- Average True Range (ATR)
- WGSWW 0.01
- GTERU 0.00
- MACD
- WGSWW 0.00
- GTERU 0.00
- Stochastic Oscillator
- WGSWW 32.46
- GTERU 0.00
About WGSWW GeneDx Holdings Corp.
GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. The company is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world's substantial rare disease data sets.